Cardiff, United Kingdom

Plinio Perrone



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Plinio Perrone: Innovator in Anti-Viral Agents

Introduction

Plinio Perrone is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-viral agents. His work focuses on innovative compounds that target viral infections, specifically hepatitis C virus.

Latest Patents

Perrone holds a patent for "Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of hepatitis C virus." This patent describes compounds with enhanced inhibitory potency, which are useful in methods of prophylaxis or treatment of viral infections. The compounds are phosphoramidate derivatives of nucleoside compounds derived from bases such as adenine and guanine. The glycoside moiety of the nucleoside compound can be substituted at the 2' position with methyl, and the phosphoramidate group can be linked to the phosphorus atom by a 1-naphthyl group. These compounds can be administered as pharmaceutical compositions, and methods for their preparation are also provided.

Career Highlights

Throughout his career, Plinio Perrone has worked with various organizations, including University College Cardiff Consultants Limited and K.U. Leuven Research & Development. His expertise in the field has led to advancements in the treatment of viral infections.

Collaborations

Perrone has collaborated with notable individuals in his field, including Christopher McGuigan and Johan Neyts. These partnerships have contributed to the development of innovative solutions in anti-viral research.

Conclusion

Plinio Perrone's work in the development of anti-viral agents showcases his commitment to advancing medical science. His innovative patents and collaborations highlight his significant impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…